Digital coach in the ER could boost addiction treatment rates

NCT ID NCT06799117

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a digital tool called EMBED that helps emergency doctors identify patients with opioid use disorder and start them on buprenorphine, a medication that reduces cravings and withdrawal. The tool is built into the electronic health record and guides doctors through diagnosis, withdrawal assessment, and treatment steps. The trial aims to see if an improved version of the tool increases the number of patients who receive buprenorphine in the emergency department.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
clinical decision support system (EMBED CDS)
What this could lead to
If successful, this could make it easier for emergency doctors to start buprenorphine treatment for opioid use disorder, potentially helping more people get care quickly.
What could go wrong
The trial focuses on improving doctor behavior, not testing a new drug, so the direct benefit to patients depends on how well the tool works in real-world settings. Early results may not apply everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Yale New Haven Hospital

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Yale New Haven Hospital- St. Raphael

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Yale New Haven Shoreline Medical Center

    RECRUITING

    Guilford, Connecticut, 06437, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.